Position in TLX
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$4,623
+$987 QoQ
Shares Held
401
+5.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#45
of 62 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aspect Partners, LLC holds $47,512 across 14 Biotechnology names. TLX ranks #4 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21 | $10,431 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
200 | $7,078 | |
| 3 | DYN |
Dyne Therapeutics, Inc.
|
233 | $5,174 | |
| 4 | TLX |
Telix Pharmaceuticals Ltd
This page
|
401 | $4,623 | |
| 5 | LEGN |
Legend Biotech Corp
|
160 | $4,620 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
10 | $3,716 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
59 | $3,375 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5 | $3,117 |
All Filings in TLX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,623 | 401 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $3,636 | 380 | Shares | Sole | 2026-04-02 | |
| 2025-12-31 | $2,636 | 352 | Shares | Sole | 2026-01-23 | |
| No filing history on record for this holder in this stock. | ||||||